Mapping Drug Interactions at the Covalent Topoisomerase II-DNA Complex by Bisantrene/Amsacrine Congeners*
暂无分享,去创建一个
S. Moro | B. Gatto | F. Zunino | G. Capranico | M. Palumbo | G. Zagotto | C. Sissi | E. Menta | F. Guano
[1] M. Palumbo. Advances in DNA Sequence Specific Agents , 1998 .
[2] G. Capranico,et al. Synthesis, DNA-damaging and cytotoxic properties of novel topoisomerase II-directed bisantrene analogues. , 1998, Bioorganic & medicinal chemistry letters.
[3] M. Palumbo. Introduction to DNA sequence-specific agents , 1998 .
[4] C. Dykes,et al. Human genome project Europe. , 1997, Trends in pharmacological sciences.
[5] Y. Pommier. DNA Topoisomerase II Inhibitors , 1997 .
[6] B. Teicher. Cancer Therapeutics: Experimental And Clinical Agents , 1997, Nature Medicine.
[7] F. Zunino,et al. Drug sensitivity and sequence specificity of human recombinant DNA topoisomerases IIalpha (p170) and IIbeta (p180). , 1996, Molecular pharmacology.
[8] W. Denny,et al. Molecular origins of selectivity in the interaction of amsacrine-4-carboxamide with GC-rich sequences in DNA. , 1996, Anti-cancer drug design.
[9] N. Osheroff,et al. Topoisomerase Poisons: Harnessing the Dark Side of Enzyme Mechanism (*) , 1995, The Journal of Biological Chemistry.
[10] K. Kohn,et al. Interaction of an alkylating camptothecin derivative with a DNA base at topoisomerase I-DNA cleavage sites. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[11] G. Capranico,et al. Topoisomerase II DNA cleavage stimulation, DNA binding activity, cytotoxicity, and physico-chemical properties of 2-aza- and 2-aza-oxide-anthracenedione derivatives. , 1995, Molecular pharmacology.
[12] F. Zunino,et al. Base sequence determinants of amonafide stimulation of topoisomerase II DNA cleavage. , 1995, Nucleic acids research.
[13] K. Kreuzer,et al. Localization of an aminoacridine antitumor agent in a type II topoisomerase-DNA complex. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[14] I. Hickson,et al. Structure and function of type II DNA topoisomerases. , 1994, The Biochemical journal.
[15] F. Zunino,et al. Conformational drug determinants of the sequence specificity of drug-stimulated topoisomerase II DNA cleavage. , 1994, Journal of molecular biology.
[16] K. Kohn,et al. Distribution of topoisomerase II cleavage sites in simian virus 40 DNA and the effects of drugs. , 1991, Journal of molecular biology.
[17] K. Kohn,et al. Local base sequence preferences for DNA cleavage by mammalian topoisomerase II in the presence of amsacrine or teniposide. , 1991, Nucleic acids research.
[18] K W Kohn,et al. Effect of local DNA sequence on topoisomerase I cleavage in the presence or absence of camptothecin. , 1991, The Journal of biological chemistry.
[19] N. Osheroff,et al. Catalytic function of DNA topoisomerase II , 1991, BioEssays : news and reviews in molecular, cellular and developmental biology.
[20] B. Baguley. DNA intercalating anti-tumour agents. , 1991, Anti-cancer drug design.
[21] K. Kohn,et al. Local sequence requirements for DNA cleavage by mammalian topoisomerase II in the presence of doxorubicin. , 1990, Nucleic acids research.
[22] M. Karol,et al. DNA binding by antitumor anthracene derivatives. , 1990, Journal of medicinal chemistry.
[23] F. Zunino,et al. Evidence of DNA topoisomerase II-dependent mechanisms of multidrug resistance in P388 leukemia cells. , 1990, Molecular pharmacology.
[24] L. Liu,et al. DNA topoisomerase poisons as antitumor drugs. , 1989, Annual review of biochemistry.
[25] B. Pullman,et al. Energetics and stereochemistry of DNA complexation with the antitumor AT specific intercalators tilorone and m-AMSA. , 1988, Nucleic acids research.
[26] Warren J. Hehre,et al. AB INITIO Molecular Orbital Theory , 1986 .
[27] Eamonn F. Healy,et al. Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model , 1985 .
[28] P. V. von Hippel,et al. Theoretical aspects of DNA-protein interactions: co-operative and non-co-operative binding of large ligands to a one-dimensional homogeneous lattice. , 1974, Journal of molecular biology.